REPORTS OF SUSPECTED CYTARABINE SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Cytarabine. The information is not vetted and should not be considered as verified clinical evidence.
Possible Cytarabine side effects / adverse reactions in 55 year old female
Reported by a physician from Japan on 2011-10-03
Patient: 55 year old female weighing 43.3 kg (95.3 pounds)
Reactions: Septic Shock
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Doxorubicin Hydrochloride
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-07-20
End date: 2011-09-06
Etoposide
Dosage: 100 mg/m2, x 1 / 4week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-07-28
End date: 2011-07-30
KW-0761
Dosage: 1.0 mg/kg, x 1 / 2week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-07-14
End date: 2011-08-17
Prednisolone
Dosage: 40 mg/m2, x 1 / 4week
Administration route: Oral
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-07-13
End date: 2011-08-18
Vindesine Sulfate
Dosage: 2.4 mg/m2, x 1 / 4week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-07-28
End date: 2011-07-28
Doxorubicin Hydrochloride
Dosage: 40 mg/m2 x 1/4week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-07-13
End date: 2011-08-18
Methotrexate Sodium
Dosage: 15 mg, 1 / 8week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-08-16
Cyclophosphamide
Dosage: 350 mg/m2, x 1 /4week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-07-13
End date: 2011-08-18
Prednisolone
Dosage: 40 mg/m2, x 1 / 4week
Administration route: Oral
Start date: 2011-07-28
End date: 2011-07-30
Ranimustine
Dosage: 60 mg/m2, x 1 / 4week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-07-20
End date: 2011-09-06
Prednisolone Sodium Succinate INJ
Dosage: 10 mg, x 1 / 8week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-08-16
Cytarabine
Dosage: 40 mg, x 1 / 8week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-08-16
Vincristine Sulfate
Dosage: 1 mg/m2, x 1 / 4week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-07-13
End date: 2011-08-18
Prednisolone
Dosage: 40 mg/m2, x 1 / 4week
Administration route: Oral
Start date: 2011-07-20
End date: 2011-09-06
Carboplatin
Dosage: 250 mg/m2, x 1 / 4week
Indication: Adult T-Cell Lymphoma/leukaemia
Start date: 2011-07-28
End date: 2011-07-28
Other drugs received by patient: Solu-Medrol; Levothyroxine Sodium; Prepenon; Amizet; Potassium Phosphate Dibasic; Neoparen No.2; Funguard; Intrafat; NEO-Mercazole TAB; Sodium Bicarbonate; Pasil; Famotidine
Possible Cytarabine side effects / adverse reactions in 34 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2011-10-03
Patient: 34 year old female weighing 65.5 kg (144.1 pounds)
Reactions: Drug Interaction, Sinus Tachycardia, Sinoatrial Block, Sinus Bradycardia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Noxafil
Dosage: 400 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Hepatosplenic Candidiasis
Start date: 2007-10-19
End date: 2008-01-25
Etoposide
Indication: Product Used FOR Unknown Indication
Acyclovir
Dosage: 200 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ondansetron
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Vogalene
Indication: Product Used FOR Unknown Indication
Allopurinol
Dosage: 100 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cytarabine
Indication: Product Used FOR Unknown Indication
Pantoloc /01263204/)
Dosage: 40 mg milligram(s)
Indication: Product Used FOR Unknown Indication
Start date: 2008-01-22
End date: 2008-01-25
Potassium Chloride
Dosage: 750 mg milligram(s), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Cytarabine side effects / adverse reactions in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-03
Patient: 54 year old male
Reactions: Fungal Infection, Pyrexia, Neutropenia, Septic Shock
Adverse event resulted in: death
Suspect drug(s):
Cytarabine
Dosage: 30 mg, unk
Idarubicin HCL
Dosage: unk ukn, unk
Hydrocortisone
Dosage: 12.5 mg, unk
Methotrexate
Dosage: 12.5 mg, unk
Etoposide
Dosage: unk ukn, unk
Other drugs received by patient: Amphotericin B
|